About us
As a modern pharmaceutical enterprise, Jiangsu Kangbeide Pharmaceutical Co., Ltd. is mainly engaged in the research, product development, production, trade and service of topical transdermal technologies. We are the first enterprise all over Asia, with a complete value chain in the field of "transdermal patch". We changed our name as "Kangbeide" since December, 2010 and founded technology development center in Beijing city in March, 2013.
Located in Zhongshan Science & Technology Park in Nanjing city of Jiangsu Province, our company covers an area of 26,680sqm and own over 6,000 square meters of cGMP approved modern plants and office buildings. Under the supports of the international advanced production, quality control equipment and public assistance systems, we now have the good abilities to provide international high quality products in low Chinese costs.
At present, we are mainly focused on the Niche market of pharmaceutical market- innovative and generic systemic passive transdermal patch and topical Gel paste, as well as related Pharmaceutical excipients and APIs, and the product areas are involving in mental and nervous system, urinary system, cardiovascular system, respiratory system, hormone replacement and pain. Currently, we are in a transition stage from "pure transdermal R & D type" to "stressing both on R & D and production". Up to now, we have obtained the "drug production licenses" (transdermal patch, Gel paste, Pharmaceutical excipients and APIs) and "registration certificate of Type A medical equipment".
VISION
We want to develop transdermal delivery system for drugs as many as possible, and promote the popularization of transdermal delivery system of drugs. We hope to serve physicians and patients, and improve the life quality of patients, and create interests for employees, partners and shareholders. We are committed to be a leading pharmaceutical company of transdermal preparation in the world.
MISSION
To do our best to be a leader in the research, development and production of transdermal patch technology, gradually become one of the international peer competitors;
Strengthen the study and protection of core technology in a comprehensive, systematical, in-depth way to promote the ability of continuous innovation;
Provide faithful and normative service for our customers and satisfy the individual needs of different clients.
Extensively cooperate with our strategic alliances in professional, sincere and win-win way, maintain strategic alliance partnership with all partners, and explore a better future for transdermal drug delivery, thus promote the core competence of China in this field.
